David J Handelsman1, Ken Sikaris2, Lam P Ly3. 1. Andrology Department, Concord Hospital, NSW, Australia ANZAC Research Institute, University of Sydney, Concord Hospital, NSW, Australia djh@anzac.edu.au. 2. Melbourne Pathology, Collingwood, Victoria, Australia. 3. Andrology Department, Concord Hospital, NSW, Australia.
Abstract
BACKGROUND: Age-specific trends of serum testosterone and sex hormone-binding globulin across the full lifespan have not been reported. METHODS: We deduced age-specific trends in serum testosterone and sex hormone-binding globulin in males and females between ages 10 and 90 from a large sample of consecutive results from a single large pathology laboratory. Coded results of 110,712 consecutive blood samples requesting serum testosterone over seven years (2007-2013) comprising blood testosterone, sex hormone-binding globulin and calculated free testosterone together with gender and age were analysed create smoothed age-specific centiles (2.5%, 5%, 25%, 50%, 75%, 95%, 97.5%) for males and females. RESULTS: These identified the pubertal increases in serum testosterone in males peaking at 20 years of age and remaining stable thereafter until the eighth decade. In females, circulating testosterone peaked in late adolescence and declined gradually over the next two decades but remained stable across menopause and beyond. After early childhood, serum sex hormone-binding globulin declines to a nadir in males at the age of 20 years and remains stable till the sixth decade with a gradual, progressive rise thereafter. In females, the sex hormone-binding globulin nadir is reached earlier with levels rising gradually and progressively with age thereafter and accelerating after the age of 70 years. Females also exhibit a second sex hormone-binding globulin peak during reproductive ages reflected only in upper centiles due to effects of pregnancy and oral contraceptive use in a significant minority of females. CONCLUSIONS: This large sample of clinical data provides a comprehensive profile of androgen status across the lifespan from early adolescence to late old age.
BACKGROUND: Age-specific trends of serum testosterone and sex hormone-binding globulin across the full lifespan have not been reported. METHODS: We deduced age-specific trends in serum testosterone and sex hormone-binding globulin in males and females between ages 10 and 90 from a large sample of consecutive results from a single large pathology laboratory. Coded results of 110,712 consecutive blood samples requesting serum testosterone over seven years (2007-2013) comprising blood testosterone, sex hormone-binding globulin and calculated free testosterone together with gender and age were analysed create smoothed age-specific centiles (2.5%, 5%, 25%, 50%, 75%, 95%, 97.5%) for males and females. RESULTS: These identified the pubertal increases in serum testosterone in males peaking at 20 years of age and remaining stable thereafter until the eighth decade. In females, circulating testosterone peaked in late adolescence and declined gradually over the next two decades but remained stable across menopause and beyond. After early childhood, serum sex hormone-binding globulin declines to a nadir in males at the age of 20 years and remains stable till the sixth decade with a gradual, progressive rise thereafter. In females, the sex hormone-binding globulin nadir is reached earlier with levels rising gradually and progressively with age thereafter and accelerating after the age of 70 years. Females also exhibit a second sex hormone-binding globulin peak during reproductive ages reflected only in upper centiles due to effects of pregnancy and oral contraceptive use in a significant minority of females. CONCLUSIONS: This large sample of clinical data provides a comprehensive profile of androgen status across the lifespan from early adolescence to late old age.
Authors: Shawn N Geniole; Valentina Proietti; Brian M Bird; Triana L Ortiz; Pierre L Bonin; Bernard Goldfarb; Neil V Watson; Justin M Carré Journal: Proc Biol Sci Date: 2019-05-29 Impact factor: 5.349
Authors: Elisa Fabbri; Yang An; Marta Gonzalez-Freire; Marco Zoli; Marcello Maggio; Stephanie A Studenski; Josephine M Egan; Chee W Chia; Luigi Ferrucci Journal: J Gerontol A Biol Sci Med Sci Date: 2016-02-27 Impact factor: 6.053
Authors: Madison T Ortega; Lauren Carlson; John A McGrath; Tairmae Kangarloo; Judith Mary Adams; Patrick M Sluss; Geralyn Lambert-Messerlian; Natalie D Shaw Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: Susan R Davis; Robin J Bell; Penelope J Robinson; David J Handelsman; Tom Gilbert; James Phung; Reena Desai; Jessica E Lockery; Robyn L Woods; Rory S Wolfe; Christopher M Reid; Mark R Nelson; Anne M Murray; John J McNeil Journal: J Clin Endocrinol Metab Date: 2019-12-01 Impact factor: 5.958
Authors: Madison H Fung; Brittany K Taylor; Michaela R Frenzel; Jacob A Eastman; Yu-Ping Wang; Vince D Calhoun; Julia M Stephen; Tony W Wilson Journal: Cereb Cortex Date: 2020-10-01 Impact factor: 5.357
Authors: Talia N Shirazi; Heather Self; James Cantor; Khytam Dawood; Rodrigo Cárdenas; Kevin Rosenfield; Triana Ortiz; Justin Carré; Michael A McDaniel; Ray Blanchard; Ravikumar Balasubramanian; Angela Delaney; William Crowley; S Marc Breedlove; David Puts Journal: Horm Behav Date: 2020-02-18 Impact factor: 3.587